NICE recommends SGLT-2 inhibitors with metformin at diagnosis, citing major cardiovascular, renal, and mortality benefits.
Read more about why patients with type 2 diabetes will now be offered SGLT-2 inhibitors much earlier in the treatment process ...
New guidance from NICE recommends earlier use of SGLT-2 inhibitors and personalised treatment for people with type 2 diabetes ...
People with type 2 diabetes (T2D) in England could be offered earlier access to newer treatments, including weight-loss jabs, under draft guidance from the National Institute for Health and Care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results